Ambrose Chan Amends Alset Inc. 13D Filing

TL;DR

Chan updated his Alset Inc. stake filing, watch for changes.

AI Summary

Ambrose Chan, through an amendment filed on May 24, 2024, has updated his Schedule 13D filing for Alset Inc. The filing indicates a change in beneficial ownership, though specific new percentage or dollar amounts are not detailed in this excerpt. This amendment continues to track Chan's holdings in Alset Inc., a company previously known as Alset EHome International Inc.

Why It Matters

This filing update signals potential shifts in significant shareholder control or strategy for Alset Inc., which could impact its stock performance and future business direction.

Risk Assessment

Risk Level: medium — Schedule 13D filings often precede significant corporate actions or changes in control, introducing uncertainty.

Key Players & Entities

• Alset Inc. (company) — Subject company
• Chan Heng Fai Ambrose (person) — Filing person
• Alset EHome International Inc. (company) — Former company name
• HF Enterprises Inc. (company) — Previous former company name

FAQ

Key Financial Figures

• $0.001 — me of issuer) Common Stock, Par Value $0.001 Per Share (Title of class of securiti
• $1.65 — at a weighted average purchase price of $1.65 per share. This transaction was execute
• $1.55 — multiple trades at prices ranging from $1.55 to $1.70. On June 29, 2023, Mr. Chan a
• $1.70 — trades at prices ranging from $1.55 to $1.70. On June 29, 2023, Mr. Chan acquired 1
• $1.72 — at a weighted average purchase price of $1.72 per share. This transaction was execute
• $1.67 — multiple trades at prices ranging from $1.67 to $1.76. On May 24, 2024, Mr. Chan a
• $1.76 — trades at prices ranging from $1.67 to $1.76. On May 24, 2024, Mr. Chan acquired 2
• $0.70 — suer’s common stock at a price of $0.70 per share in a private transaction. O
• $0.667 — at a weighted average purchase price of $0.667 per share . This transaction was execut
• $0.546 — multiple trades at prices ranging from $0.546 to $0.70. On May 28, 2024, Mr. Chan a
• $0.741 — at a weighted average purchase price of $0.741 per share. This transaction was execute
• $0.73 — multiple trades at prices ranging from $0.73 to $0.80. Item 4. Purpose of Transact
• $0.80 — trades at prices ranging from $0.73 to $0.80. Item 4. Purpose of Transaction All

Filing Documents

• formsc13da.htm (SC 13D/A) — 70KB
• 0001493152-24-021853.txt ( ) — 72KB

of t he

Item 3 of t he Schedule 13D is hereby amended to include the following: On June 28, 2023, Mr. Chan acquired 10,000 shares of the Issuer’s common stock at a weighted average purchase price of $1.65 per share. This transaction was executed in multiple trades at prices ranging from $1.55 to $1.70. On June 29, 2023, Mr. Chan acquired 10,000 shares of the Issuer’s common stock at a weighted average purchase price of $1.72 per share. This transaction was executed in multiple trades at prices ranging from $1.67 to $1.76. On May 24, 2024, Mr. Chan acquired 233,092 shares of the Issuer’s common stock at a price of $0.70 per share in a private transaction. On May 24, 2024, Mr. Chan acquired 223,396 shares of the Issuer’s common stock at a weighted average purchase price of $0.667 per share . This transaction was executed in multiple trades at prices ranging from $0.546 to $0.70. On May 28, 2024, Mr. Chan acquired 67,215 shares of the Issuer’s common stock at a weighted average purchase price of $0.741 per share. This transaction was executed in multiple trades at prices ranging from $0.73 to $0.80. Item 4. Purpose of Transaction All of the Issuer’s securities owned by the Reporting Person have been acquired for investment purposes only. As of the date of this Schedule 13D, the Reporting Person has no present plans or proposals that relate to or would result in any of the actions required to be described in subsections (a) through (j) of Item 4 of Schedule 13D. The Reporting Person may, at any time, review or reconsider its positions with respect to the Issuer and formulate plans or proposals with respect to any of such matters, but have no present intention of doing so. Item 5. Interest in Securities of the Issuer (a) In the Aggregate, the Reporting Persons beneficially 5,466,521 shares, or 59.2%, of the Issuer’s common stock. The percentages in this paragraph relating to beneficial ownership of Common Stock are based

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: May 29, 2024 By: /s/ Heng Fai Ambrose Chan Name: Heng Fai Ambrose Chan HFE Holdings Limited Dated: May 29, 2024 By: /s/ Heng Fai Ambrose Chan Name: Heng Fai Ambrose Chan Title: Director

View Full Filing

View this SC 13D/A filing on SEC EDGAR